Q4 2024 Surgical Science Sweden AB Earnings Call Transcript
Key Points
- Surgical Science Sweden AB (SUSRF) achieved record sales of SEK252 million in Q4 2024, marking a strong end to the year.
- The company secured a significant procurement order worth SEK52 million in Southeast Asia for a virtual or mixed reality solution, indicating potential growth in new customer segments.
- Sales of simulators to non-robotic customers in the medical device space grew by 124%, reaching an all-time high of SEK43 million.
- A new agreement with Intuitive, the world's largest robotics manufacturer, ensures that all new Da Vinci 5 systems will be equipped with Surgical Science's simulation software.
- The acquisition of UK-based Intelligent Ultrasound positions Surgical Science as a market leader in ultrasound simulation, expanding its product portfolio and market reach.
- The educational products segment experienced only a 2% growth, falling short of the company's growth expectations of 10% to 15%.
- The American market saw a 20% decrease in sales, highlighting regional challenges.
- Profitability was affected by higher costs related to sales incentives and a higher share of sales from distributors, which negatively impacted margins.
- The transition to a fully subscription-based model with Intuitive may have short-term revenue implications due to the spread of revenues over time.
- The global budgetary climate for hospitals and training centers remains strained, prolonging the conversion of quotes into orders.
Welcome to Surgical Science Q4 report 2024. For the first part of the presentation, participants will be in listen-only mode. (Operator Instructions) I will now hand over to CEO, Tom Englund and CFO, Anna Ahlberg.
Welcome to this year-end and quarter four presentation of Surgical Science. My name is Tom Englund, CEO of Surgical Science, and with me today I have Anna Ahlberg, our company CFO. We'll use our time together today to first present the report and then we will take questions from the audience.
We can look back at an eventful and positive fourth quarter for surgical science and a good end to 2024. The year started weekly with a tough business environment and educational products. Our turnaround came in quarter two of last year, and sales and marketing market conditions have since steadily improved during the year to end with record sales for the group of SEK252 million.
Starting with educational products, the quarter saw a growth for the business area of 2% to SEK125
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
